Search Results - "Hausner, Petr F."

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    18F-FDG PET/CT in a Recurrent Diffuse Malignant Peritoneal Mesothelioma by Cao, Qi, Lu, Minh, Heath, Jonathon, Hausner, Petr F, Alexander, H Richard, Dilsizian, Vasken, Chen, Wengen

    Published in Clinical nuclear medicine (01-05-2012)
    “…Peritoneal mesothelioma is a rare and aggressive tumor. Early diagnosis of the disease is difficult, delaying effective treatment. We report a case of…”
    Get full text
    Journal Article
  5. 5

    Combination Nivolumab/Ipilimumab Immunotherapy For Melanoma With Subsequent Unexpected Cardiac Arrest: A Case Report and Review of Literature by Khoury, Zaid H, Hausner, Petr F, Idzik-Starr, Cynthia L, Frykenberg, Matthew R A, Brooks, John K, Dyalram, Donita, Basile, John R, Younis, Rania H

    Published in Journal of immunotherapy (1997) (01-10-2019)
    “…The success of immunotherapy in the treatment of patients with advanced melanoma has paved the way for unprecedented successes in the treatment of many other…”
    Get full text
    Journal Article
  6. 6

    Radiation Therapy and Malignant Fistulae of Anorectal Cancers by Koroulakis, Antony I., Molitoris, Jason K., Sullivan, Michael, Jiang, Yixing, Hausner, Petr F., Hanna, Nader, Bafford, Andrea, Miller, Robert C., Regine, William F.

    Published in Practical Radiation Oncology (01-11-2022)
    “…Although fistulization is a well-studied late toxic effect of radiation therapy (RT), anorectal cancers (ARCs) can present with malignant fistulae (MF) and…”
    Get full text
    Journal Article
  7. 7

    Case report of capecitabine toxicity and use of uridine triacetate by Oliver, Wesley D, Duffy, Alison P, Hausner, Petr F

    Published in Journal of oncology pharmacy practice (01-03-2019)
    “…Fluorouracil and capecitabine are fluoropyrimidine chemotherapy agents that are commonly used for various cancers. These agents are generally well tolerated at…”
    Get full text
    Journal Article
  8. 8

    Stereotactic Ablative Radiotherapy (SABR): Impact on the Immune System and Potential for Future Therapeutic Modulation by Reese, Adam S, Feigenberg, Steven J, Husain, Azmat, Webb, Tonya J, Hausner, Petr F, Edelman, Martin J, Feliciano, Josephine, Tkaczuk, Katherine H, Sharma, Navesh K

    “…Stereotactic ablative radiotherapy (SABR) has been demonstrated to provide excellent local control in several malignancies. Recent reports have suggested that…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Phase I study of docetaxel and topotecan in patients with solid tumors by TKACZUK, Katherine H, ZAMBONI, William C, TAIT, Nancy S, MEISENBERG, Barry R, DOYLE, L. Austin, EDELMAN, Martin J, HAUSNER, Petr F, EGORIN, Merrill J, VAN ECHO, David A

    “…Both docetaxel (DOC), a promoter and stabilizer of microtubule assembly, and topotecan (TOPO), a topoisomerase I inhibitor, have shown antitumor activity in a…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20